Skip to main content

Table 2 Association of ACAG with NAFLD

From: Relationship between albumin-corrected anion gap and non-alcoholic fatty liver disease varied in different waist circumference groups: a cross-sectional study

 

β (95% CI)

  

OR (95% CI)

  

OR* (95% CI)

  

Factors

Crude

Model 1

Model 2

Crude

Model 1

Model 2

Crude

Model 1

Model 2

ACAG level

3.746 (3.015, 4.478)

1.121 (0.475, 1.766)

1.166 (0.529, 1.802)

1.117 (1.088, 1.147)

1.047 (1.019, 1.081)

1.011 (1.005, 1.017)

1.130 (1.103, 1.159)

1.061 (1.029, 1.095)

1.064 (1.029, 1.101)

ACAG subgroups

 Tertile 1

Refs.

Refs.

Refs.

Refs.

Refs.

Refs.

Refs.

Refs.

Refs.

 Tertile 2

13.389 (8.938, 17.841)

6.802 (2.959, 10.645)

5.232 (1.557, 8.907)

1.640 (1.402, 1.918)

1.539 (1.268, 1.867)

1.421 (1.161, 1.739)

1.486 (1.285, 1.718)

1.350 (1.124, 1.623)

1.247 (1.030, 1.510)

 Tertile 3

22.353 (17.900, 26.807)

7.491 (3.561, 11.421)

5.814 (2.047, 9.580)

1.936 (1.658, 2.261)

1.387 (1.141, 1.685)

1.286 (1.049, 1.577)

1.986 (1.718, 2.296)

1.395 (1.157, 1.682)

1.323 (1.089, 1.607)

 P for trend

 < 0.001

 < 0.001

0.002

 < 0.001

0.001

0.017

 < 0.001

 < 0.001

0.004

  1. Data in the table: β: CAP; OR: NAFLD (CAP cutoff point of 285 dB/m); OR*: NAFLD (CAP cutoff point of 263 dB/m).
  2. CAP controlled attenuation parameter, 95% CI 95% confidence interval, OR odds ratio, ACAG albumin-corrected anion gap